Rhenman & Partners Asset Management Ab Adamas Pharmaceuticals, Inc. Transaction History
Rhenman & Partners Asset Management Ab
- $959 Million
- Q4 2024
Shares
7 transactions
About Adamas Pharmaceuticals, Inc.
- Ticker ADMS
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,408,100
- Market Cap $376M